Heart failure drug approved by EULouth LeaderSeveral other newspapers have reported on the drug ivabradine, known by the brand name Procoralan, as European drug regulators have today approved it for the treatment of chronic heart failure. In heart fail…
Mother tells of organ donation – The Press Association
ScotsmanMother tells of organ donationThe Press AssociationShe spoke out as she visited Daryl's old school, Holy Cross High School in Hamilton, with Health Secretary Nicola Sturgeon to see his friends and teachers use a teaching pack on organ donat…
A tall order for VGTI – Finding a Cure for HIV – Florida Trend
Florida TrendA tall order for VGTI – Finding a Cure for HIVFlorida TrendHe was a student in the days when Christiaan Barnard and Michael DeBakey pioneered the first heart transplants, and he became fascinated with transplant rejection, the immune syste…
Recipharm to manufacture ViroPharma Plenadren tablet – Pharmaceutical Business Review
Recipharm to manufacture ViroPharma Plenadren tabletPharmaceutical Business ReviewViroPharma has contracted Recipharm for the commercial scale-up production of Plenadren (Hydrocortisone, Modified Release Tablet), used for the treatment of adrenal insuf…
Premier League – Paper Round: Doc ran from crowd to help Muamba – Yahoo! Eurosport UK
Yahoo! Eurosport UKPremier League – Paper Round: Doc ran from crowd to help MuambaYahoo! Eurosport UKFabrice Muamba's fight for life following his heart failure during an FA Cup match on Saturday dominates Monday's newspapers. The Sun and the D…
Shrewsbury organ donation campaigner Ben Hughes dies – BBC News
BBC NewsShrewsbury organ donation campaigner Ben Hughes diesBBC NewsA Shropshire man who spent his last months raising awareness of the need for more transplant organs has died. Ben Hughes, 28, from Shrewsbury was born with congenital heart disease and…
Genmab Submits Protocol Amendment For Ofatumumab Phase 3 Head-to-head Study – NASDAQ
Genmab Submits Protocol Amendment For Ofatumumab Phase 3 Head-to-head StudyNASDAQAccording to the amended protocol all patients recruited in the study which investigates ofatumumab plus chemotherapy versus rituximab plus chemotherapy in relapsed or ref…
Genmab Submits Protocol Amendment For Ofatumumab Phase 3 Head-to-head Study – RTT News
Genmab Submits Protocol Amendment For Ofatumumab Phase 3 Head-to-head StudyRTT NewsAccording to the amended protocol all patients recruited in the study which investigates ofatumumab plus chemotherapy versus rituximab plus chemotherapy in relapsed or r…
HeartWare gets US FDA nod for IDE enrollment in bridge-to-transplant trial … – pharmabiz.com
HeartWare gets US FDA nod for IDE enrollment in bridge-to-transplant trial …pharmabiz.comHeartWare International Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advan…
Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL – MarketWatch (press release)
Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCLMarketWatch (press release)According to the amended protocol all patients recruited in the study which investigates ofatumumab plus chemotherapy versus rituximab plus chemotherap…